DR. JULIE ELAINE BAUMAN, M.D. MPH
Osteopathic Medicine at Camino De Salud, Albuquerque, NM

License number
New Mexico MD2008-0704
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
1201 Camino De Salud NE, Albuquerque, NM 87102
Phone
(505) 272-4946
(505) 272-3120
(505) 272-8060 (Fax)

Personal information

See more information about JULIE ELAINE BAUMAN at radaris.com
Name
Address
Phone
Julie Bauman
12001 Calle Zagal NE, Albuquerque, NM 87111

Professional information

Julie E Bauman Photo 1

Dr. Julie E Bauman, Pittsburgh PA - MD (Doctor of Medicine)

Specialties:
Oncology, Medical Oncology
Address:
5150 Centre Ave SUITE 5, Pittsburgh 15232
(412) 648-6507 (Phone), (412) 692-4705 (Fax)
UNIVERSITY OF NEW MEXICO CANCER CENTER
900 Camino De Salud, Albuquerque 87102
(505) 272-6337 (Phone), (505) 272-2841 (Fax)
Hillman Cancer Center
5150 Centre Ave, Pittsburgh 15232
(412) 692-4724 (Phone), (412) 692-4701 (Fax)
Certifications:
Internal Medicine, 2003, Medical Oncology, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Tufts University
Graduated: 1999


Julie E Bauman M.p.h. Photo 2

Julie E Bauman M.P.H., Albuquerque NM

Specialties:
Internal Medicine, Medical Oncology, Hematology & Oncology, Hematology, Plastic Surgery Within the Head and Neck
Work:
Cancer Research & Treatment Center
1201 Camino De Salud NE, Albuquerque, NM 87102 Cancer Research & Treatment Center
900 Camino De Salud Ne, Albuquerque, NM 87131 UNM Medical Group Inc
2211 Lomas Blvd NE, Albuquerque, NM 87106 Cancer Research & Treatment Center
715 Dr Martin Luther King Jr Ave NE, Albuquerque, NM 87102
Education:
Tufts University (1999)


Julie Bauman Photo 3

Methods For Treating Infection By Hpv

US Patent:
2012026, Oct 25, 2012
Filed:
Apr 25, 2012
Appl. No.:
13/455665
Inventors:
MICHELLE A. OZBUN - Albuquerque NM, US
Julie E. Bauman - Albuquerque NM, US
International Classification:
A61K 39/395, A61P 35/00, A61P 31/12
US Classification:
4241521
Abstract:
We describe herein methods for treating HPV infections and medical conditions caused by HPV infections. Generally, the methods include administering to a subject exhibiting at least one symptom or clinical sign of HPV infection a composition that includes an EGFR signaling inhibitor in an amount effective to ameliorate the at least one symptom or clinical sign of HPV infection.